Meet Our Team

A multidisciplinary team combining clinical excellence, scientific rigor, and entrepreneurial vision to advance affordable diabetes interventions from traditional knowledge to FDA approval.

Home / Team

Project Leadership

Reverend Sam Adeyemi - Founder & Lead Investigator
Founder & Lead

Reverend Sam Adeyemi

Founder & CEO | Digital Growth Strategist | Software Engineer

A unique blend of spiritual leadership and technical excellence drives the HUNTER Trial's mission. Rev. Adeyemi brings together a Master's degree in Software Engineering, deep understanding of African markets, and a vision to bridge global technology with local market dynamics. Based in the UK with Nigerian roots, he provides the international perspective and cross-cultural fluency essential for advancing African traditional medicine through modern FDA-aligned pathways.

His work spans digital transformation, AI-powered solutions, and business development skills directly applied to building the infrastructure, partnerships, and regulatory frameworks needed to bring HSE-01 from concept to clinical reality. Beyond technical expertise, his background in spiritual leadership and mentorship anchors the project's commitment to ethical benefit-sharing, community engagement, and health equity for underserved populations.

Qualifications & Expertise

Master of Science in Software Engineering
8+ years in digital transformation
Cross-cultural business development
AI-powered marketing solutions
Spiritual leadership & mentorship
Strategic partnerships & fundraising

Scientific Advisory Board

Independent experts in endocrinology, clinical pharmacology, botanical drug development, and biostatistics who provide scientific oversight, protocol review, and data safety monitoring for the HUNTER Trial.

DR

Dr. [Name TBD]

Chief Medical Advisor

Board-certified endocrinologist with 20+ years in diabetes clinical trials. Former PI on 15+ Phase II/III studies. Expertise in diabetes remission protocols and GCP compliance.

DR

Dr. [Name TBD]

Botanical Drug Specialist

Clinical pharmacologist with expertise in FDA botanical drug pathway. Published 40+ papers on natural product pharmacokinetics and phytochemistry. Former FDA reviewer.

DR

Dr. [Name TBD]

Biostatistician & DSMB Chair

PhD in biostatistics with 15+ years chairing Data Safety Monitoring Boards. Expertise in adaptive trial designs, interim analyses, and regulatory submissions.

DR

Prof. [Name TBD]

Ethnobotany & Traditional Medicine

Leading authority on West African medicinal plants. Professor at [University]. Published extensively on Hunteria species and benefit-sharing frameworks (Nagoya Protocol).

DR

Dr. [Name TBD]

Regulatory Affairs Consultant

Former regulatory affairs director at major pharmaceutical company. Expert in IND applications, FDA botanical drug guidance, and international harmonization (ICH guidelines).

Actively Recruiting

Join Our Advisory Board

We are seeking additional advisors in nutrition/dietetics, exercise physiology, health economics, and community engagement. Express interest

Partners & Collaborators

Confirmed

GMP Manufacturing Partner

[Partner Name TBD]
Specialized botanical extract manufacturer with FDA-registered facility. Expertise in standardized phytochemical extraction, quality control (HPLC), and stability testing. Preliminary quote provided for HSE-01 production ($250-350K for trial supply).

In Discussion

Clinical Research Organization (CRO)

[Partner Name TBD]
Full-service CRO with expertise in Phase I/II diabetes trials. Under discussion for clinical operations, site monitoring, data management, and regulatory support. Proposal review in progress.

Confirmed

Central Laboratory Services

[Partner Name TBD]
CAP/CLIA-accredited clinical laboratory specializing in metabolic biomarkers (glucose, HbA1c, insulin, C-peptide). Committed to supporting HUNTER Trial with priority turnaround and bulk pricing.

In Discussion

Clinical Trial Site

[Institution Name TBD]
Academic medical center with active diabetes clinic serving target population (early T2D). IRB-approved protocol review underway. Principal investigator identified and engaged.

Join Us in Advancing This Work

We're actively building our team and welcome inquiries from clinical investigators, scientific advisors, regulatory consultants, and institutional partners. If you're passionate about advancing affordable, evidence-based diabetes interventions, let's talk.

Explore Partnerships Contact Our Team